483 Sagent Pharmaceuticals May 2012

483 Sagent Pharmaceuticals May 2012

Debra Love FDA$119.00 - Available Now

FDA investigators audited the Sagent Pharmaceuticals - Schaumburg, IL, United States facility and issued 2 inspectional observations (via FDA 483) on 11 May 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 11 May 2012
  • Location: Schaumburg, United States
  • FEI: 3006167046
Add To Cart